Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
PetMed Express, Inc. (PETS) - free report >>
Petco Health and Wellness Company, Inc. (WOOF) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PetMed Express, Inc. (PETS) - free report >>
Petco Health and Wellness Company, Inc. (WOOF) - free report >>
Image: Bigstock
Time for Pet ETF on Upbeat Earnings from Chewy? (Revised)
Chewy Inc. (CHWY - Free Report) , the renowned online retailer for pet products, has left investors and pet enthusiasts delighted with its latest earnings report. Shares surged 17.4% in the pre-market session on Jun 1, 2023. This remarkable performance was fueled by Chewy's exceptional sales figures, driven by its recurring-purchase program and strong customer loyalty.
Chewy reported earnings of $0.20 per share in Q1, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.04 per share a year ago. Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Chewy's Impressive Sales Results
Chewy, which belongs to the Zacks Consumer Products - Staples industry, posted revenues of $2.78 billion for the quarter ended April 2023, surpassing the Zacks Consensus Estimate by 1.87%. This compares to year-ago revenues of $2.43 billion. The company has topped consensus revenue estimates three times over the last four quarters.
Chewy's success can be attributed to its ability to attract and retain customers through innovative strategies. The company reported record-breaking net sales per active customer, surpassing $500, representing a remarkable 15% increase compared to the previous year. Chewy's Autoship program, which offers prescription refills, discounts, and scheduled deliveries, has played a crucial role in boosting customer loyalty and driving sales growth.
Not All Companies in the Pink: Tap the Industry With ETF at Lesser Risks
While Chewy celebrated its thriving sales, rival Petco Health & Wellness Co. (WOOF - Free Report) faced a different fate. Petco experienced a significant decline in its stock value following disappointing results. PetMed (PETS - Free Report) too missed earnings and revenue estimates released in late May.
The contrasting fortunes of Chewy and other players highlight Chewy's ability to adapt to market conditions. It also raises the question: Is now the right time for investors to play the industry in ETF form?
ProShares Pet Care ETF (PAWZ - Free Report) ) in Focus
Given Chewy's stellar performance and optimistic outlook, investors might consider exploring the potential of the pure-play Pet ETF. Chewy has about 8.18% in the fund PAWZ.
(We are reissuing this article to correct a mistake. The original article, issued on Jun 1, 2023, should no longer be relied upon.)